Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Look for warning indicators such as overspending, debt drift, and shrinking savings, then apply targeted corrections to stabilize finances.
16,739 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
PepsiCo unveils a landmark Asia strategy, reframing markets into three asias, three different playbooks to capture gr...
Want exposure to AI chip growth without chasing volatile hype? This article breaks down the 3 core reasons taiwan sem...
Geopolitics are shaping the tech supply chain, and Taiwan Semiconductor sits at the center. This guide breaks down wh...
Investors paused on news from Middle East diplomacy talks, pushing the Nasdaq Composite lower as rates and energy mar...
With megacap dominance fading, traders are rethinking how to beat without magnificent risk. Equal-weight strategies a...
In Florida, trump hates voting mail—except, as ballots are cast, the president shows a paradox that highlights the po...
QVC is leaning into TikTok's live shopping fever as traditional TV fades. The move aims to spark a new growth engine ...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
A sudden explosion at Valero’s Port Arthur refinery prompted a temporary shutdown, sending ripples through energy mar...
A new science council linked to Trump signals a stronger link between AI and crypto policy. This morning minute exami...
A Middle East conflict could lift oil prices and boost inflation in the United States, prompting fresh debates about ...